1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
CA 2370141 A1 · Owner: Dupont Pharmaceuticals Company · Inventors: Wang, Haisheng; Rodgers, James D.; Johnson, Barry L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to 1,4-benzodiazepin-2-ones of Formula (I) or stereoisomeric forms, stereoisomeric mixtures or pharmaceutically acceptable , salt forms thereof which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.